To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Pfizer

Status and phase: Completed; Phase 2

Conditions: Diabetes Mellitus, Type 2

Treatments: Drug: Inhaled insulin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00143338

A2171053

Details and patient eligibility

About

To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.

Sex: All

Ages: 30 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 Diabetes Mellitus
• Normal lung function

Exclusion criteria

• Smokers

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)